Catalyst Wire Dossier Catalyst Wire Dossier

OA-SYS

· Ageless Biotech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OA-SYS, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint [Phase 2]

See pricing